Target intelligence / Profile preview

Soft tissue cells

Molecular classification
Other
01

Overview

Soft tissue cells refer to a broad histological classification of cells that constitute the supportive, connective, and surrounding structures of the body's organs. This category includes diverse cell types such as myocytes, adipocytes, fibroblasts, endothelial cells, and cells of the peripheral nervous system (National Cancer Institute, 2023). These cells are essential for maintaining physiological homeostasis, providing mechanical strength, and facilitating movement through contractility. In a clinical context, soft tissue cells are the origin of various malignancies known as soft tissue sarcomas, which are often treated with therapies targeting specific intracellular pathways (StatPearls, 2023). For example, gastrointestinal stromal tumors (GIST) are treated with inhibitors targeting the KIT or PDGFRA receptors expressed on these cells. However, because 'Soft Tissue Cells' is a collective term for multiple cell lineages rather than a discrete protein or nucleic acid, it does not function as a canonical therapeutic target in drug discovery. Instead, it serves as the biological environment or tissue of origin for specific molecular targets. Consequently, the term is considered too broad and non-specific for use as a defined molecular target in pharmacological databases.

Other names
Connective tissue cellsMesenchymal cellsNon-epithelial extraskeletal tissue cells
02

Mechanism of action

Not applicable. Soft tissue cells represent a broad histological category of various cell types rather than a specific molecular target such as a receptor or enzyme.

03

Biological functions

Structural supportMetabolic storageContractilityWound healing
04

Disease associations

Soft tissue sarcomaFibrosisDesmoid tumorsLipoma
05

Safety considerations

Non-specific toxicity to healthy connective tissuesImpaired wound healing

Beyond the preview

Go deeper on Soft tissue cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soft tissue cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call